Harpoon Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview

Harpoon Therapeutics

30/07/2021 13:11

* Harpoon Therapeutics Inc  HARP.OQ   HARP.O  is expected
to show a rise in quarterly revenue when it reports results on
August 3 (estimated). 
* The South San Francisco, California-based company is expected
to report   a 151.2% increase in revenue to $6.937 million from
$2.76 million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Harpoon Therapeutics
Inc is for a loss of 43 cents per share. For the same quarter
last year, the company reported a loss of 51 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $31​, about 66.5% above​ its last closing
price of $10.40. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.42       -0.44      -0.37     Beat    16
 Dec. 31 2020  -0.48       -0.54      -0.45     Beat    16.7
 Sep. 30 2020  -0.47       -0.50      -0.53     Missed  -7​
 Jun. 30 2020  -0.48       -0.47      -0.51     Missed  -7.4
 Mar.          -0.36​      -0.41      -0.51     Missed  -23.5​
 31​ 2020​                                              
 Dec. 31 2019  -0.48       -0.53      -0.58     Missed  -9.5​
 Sep. 30 2019  -0.55       -0.55      -0.65     Missed  -18.1
 Jun. 30 2019  -0.63       -0.63      -0.49     Beat    22.5
 This summary was machine generated July 30 at 12:11 GMT.  All
figures in US dollars unless otherwise stated